Rexulti 1 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FMTRK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,567
Award facts
- Contract value 100% obligated
- $20,566.74 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $20,566.74 firm fixed-price delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Rexulti 1 mg tablets (30-count units). The contract, classified as a non-set-aside competitive award, is scheduled for completion by June 23, 2025, with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that serves as the primary vehicle for pharmaceutical procurement across the U.S. military healthcare system.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, leverages its comprehensive IDC with DLA to fulfill ongoing medical supply requirements for military and veteran healthcare systems. The Rexulti order is consistent with the company's extensive federal contract portfolio, which encompasses a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. As a critical vendor in the federal medical procurement supply chain, AmerisourceBergen maintains the capability to deliver pharmaceutical products competitively while supporting the Defense Health Agency and other government healthcare customers globally.
Quick answers
Who was awarded contract SPE2DB25FMTRK?
SPE2DB25FMTRK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 20, 2025.
How much is contract SPE2DB25FMTRK worth?
The government has obligated $20,567 on SPE2DB25FMTRK.
Is contract SPE2DB25FMTRK an order under another contract?
Yes. SPE2DB25FMTRK is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB25FMTRK competed?
The extent of competition for SPE2DB25FMTRK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award